As FDA Posts Waivers, House Okays Bill To Ban Panel Members With Conflicts

FDA has begun publishing conflict of interest waivers on its website for outside experts prior to their participation in advisory panel meetings, even as lawmakers continue to push for legislation that would ban individuals with conflicts from participating at all

More from Archive

More from Medtech Insight